APA citiranje

Spagnuolo, V., Galli, L., Poli, A., Bigoloni, A., Fumagalli, L., Gianotti, N., . . . Castagna, A. (2019). A nucleoside-sparing regimen of dolutegravir plus ritonavir-boosted atazanavir in HIV-1-infected patients with virological failure: The DOLATAV study. Drug Des Devel Ther.

Citação norma Chicago

Spagnuolo, Vincenzo, et al. "A Nucleoside-sparing Regimen of Dolutegravir Plus Ritonavir-boosted Atazanavir in HIV-1-infected Patients With Virological Failure: The DOLATAV Study." Drug Des Devel Ther 2019.

MLA citiranje

Spagnuolo, Vincenzo, et al. "A Nucleoside-sparing Regimen of Dolutegravir Plus Ritonavir-boosted Atazanavir in HIV-1-infected Patients With Virological Failure: The DOLATAV Study." Drug Des Devel Ther 2019.